Stem Cell Transplantation

Post-remission therapy with allogeneic hematopoietic-cell transplantation (allo-HCT) offers the most powerful antineoplastic therapy because of pretransplantation cytoreductive conditioning and the immunologic antileukemic graft-versus-leukemia effect.

  • Allo-HCT is often given to patients who are not likely to have an extended complete response (CR) with other traditional approaches1

Reference: 1. Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136-1152.